295 filings
Page 4 of 15
144
TRDA
Entrada Therapeutics Inc
13 Dec 23
Notice of proposed sale of securities
5:14pm
8-K
TRDA
Entrada Therapeutics Inc
6 Dec 23
Departure of Directors or Certain Officers
7:00am
CORRESP
TRDA
Entrada Therapeutics Inc
6 Dec 23
Correspondence with SEC
12:00am
8-K
TRDA
Entrada Therapeutics Inc
22 Nov 23
Entrada Therapeutics Announces Updates on ENTR-601-44 in Duchenne Muscular Dystrophy
7:35am
UPLOAD
TRDA
Entrada Therapeutics Inc
21 Nov 23
Letter from SEC
12:00am
4
TRDA
Entrada Therapeutics Inc
13 Nov 23
Entrada Therapeutics / Dipal Doshi ownership change
4:35pm
144
TRDA
Entrada Therapeutics Inc
13 Nov 23
Notice of proposed sale of securities
4:15pm
CORRESP
TRDA
Entrada Therapeutics Inc
13 Nov 23
Correspondence with SEC
12:00am
10-Q
2023 Q3
TRDA
Entrada Therapeutics Inc
Quarterly report
7 Nov 23
7:20am
8-K
TRDA
Entrada Therapeutics Inc
7 Nov 23
Entrada Therapeutics Reports Third Quarter 2023 Financial Results
7:08am
8-K
TRDA
Entrada Therapeutics Inc
1 Nov 23
Entry into a Material Definitive Agreement
7:01am
UPLOAD
TRDA
Entrada Therapeutics Inc
1 Nov 23
Letter from SEC
12:00am
4
TRDA
Entrada Therapeutics Inc
19 Oct 23
Entrada Therapeutics / Dipal Doshi ownership change
5:27pm
8-K
TRDA
Entrada Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:39pm
424B5
TRDA
Entrada Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:35pm
8-K
TRDA
Entrada Therapeutics Inc
21 Sep 23
Other Events
7:09am
4
TRDA
Entrada Therapeutics Inc
15 Sep 23
Entrada Therapeutics / Dipal Doshi ownership change
4:21pm
4
TRDA
Entrada Therapeutics Inc
6 Sep 23
Entrada Therapeutics / Dipal Doshi ownership change
5:12pm
4
Kory James Wentworth
6 Sep 23
Entrada Therapeutics / KORY JAMES WENTWORTH ownership change
5:11pm
4
Natarajan Sethuraman
6 Sep 23
Entrada Therapeutics / Natarajan Sethuraman ownership change
5:09pm